Published • loading... • Updated
Popular antidepressant recalled for high levels of a potentially cancer-causing chemical
Breckenridge recalled nearly 360,000 bottles after testing found N-nitroso-duloxetine above the FDA’s recommended limit.
- New Jersey-based Breckenridge Pharmaceutical recalled nearly 360,000 bottles of duloxetine, a generic version of Cymbalta, on June 4 after the FDA found levels of N-nitroso-duloxetine exceeded recommended limits.
- According to the FDA, nitrosamines are compounds that can form during the manufacturing, storage, or packaging of medications and may increase cancer risks if patients are exposed above acceptable levels over long periods.
- The recall affects 30-mg and 60-mg delayed-release capsules distributed nationwide, with affected 60-mg lots including 232311, 240317, and 240318, while 30-mg capsules carry lot code 241180C.
- Health officials and experts advise patients not to stop taking the medication, which treats depression, anxiety, and fibromyalgia, without first speaking to a medical professional or pharmacist.
- Recalls occur when manufacturers remove products that "present a risk of injury or gross deception or are otherwise defective," according to the FDA, which continues monitoring medication safety nationwide.
Insights by Ground AI
11 Articles
11 Articles
NBC Dallas-Fort Worth+2 Reposted by 2 other sources
Popular antidepressant recalled over elevated levels of cancer-causing compound
A popular antidepressant is being recalled because they may contain high levels of a cancer-causing compound. The New-Jersey based drug company Breckenridge Pharmaceuticals is recalling bottles of the prescription drug duloxetine, a generic version of Cymbalta. The medication is used to treat depression, anxiety and fibromyalgia, according to Mayo Clinic. According to a U.S. Food and Drug Administration enforcement report, testing of the delayed…
·Fort Worth, United States
Read Full Article
Father's Day SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources11
Leaning Left3Leaning Right0Center8Last UpdatedBias Distribution73% Center
Bias Distribution
- 73% of the sources are Center
73% Center
L 27%
C 73%
Factuality
To view factuality data please Upgrade to Premium
